NDC 71384-513

Dex-Moxi-Ketor

Dexamethasone Phosphate - Moxifloxacin - Ketorolac Tromethamine

Dex-Moxi-Ketor is a Ophthalmic Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride Monohydrate; Ketorolac Tromethamine.

Product ID71384-513_638a4320-9c22-4122-e053-2991aa0af758
NDC71384-513
Product TypeHuman Prescription Drug
Proprietary NameDex-Moxi-Ketor
Generic NameDexamethasone Phosphate - Moxifloxacin - Ketorolac Tromethamine
Dosage FormInjection, Solution
Route of AdministrationOPHTHALMIC
Marketing Start Date2018-01-05
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameImprimis NJOF, LLC
Substance NameDEXAMETHASONE SODIUM PHOSPHATE; MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE; KETOROLAC TROMETHAMINE
Active Ingredient Strength1 mg/mL; mg/mL; mg/mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Cyclooxygenase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71384-513-01

20 VIAL, SINGLE-USE in 1 BOX (71384-513-01) > 1 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2018-01-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71384-513-01 [71384051301]

Dex-Moxi-Ketor INJECTION, SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-01-05
Inactivation Date2020-01-31
Reactivation Date2020-02-10

Drug Details

Active Ingredients

IngredientStrength
DEXAMETHASONE SODIUM PHOSPHATE1 mg/mL

OpenFDA Data

SPL SET ID:62fff769-95d6-0908-e053-2a91aa0a732d
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Quinolone Antimicrobial [EPC]
  • Quinolones [CS]
  • Cyclooxygenase Inhibitors [MoA]
  • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Cyclooxygenase Inhibitor [EPC]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]

Trademark Results [Dex-Moxi-Ketor]

Mark Image

Registration | Serial
Company
Trademark
Application Date
DEX-MOXI-KETOR
DEX-MOXI-KETOR
87351119 5587077 Live/Registered
HARROW IP, LLC
2017-02-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.